We are live on ! Find out more
MDVL

MedAvail Holdings, Inc. Common Stock

Delisted

MDVL was delisted on the 12th of February, 2024.

6 hedge funds and large institutions have $140K invested in MedAvail Holdings, Inc. Common Stock in 2018 Q3 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, 2 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 66 (0)

0% more first-time investments, than exits

New positions opened: 1 | Existing positions closed: 1

31% less capital invested

Capital invested by funds: $202K → $140K (-$62K)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 2

Holders
6
Holders Change
Holders Change %
0%
% of All Funds
0.14%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
1
Increased
Reduced
2
Closed
1
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$89K -$8.71K -11 -8%
Vanguard Group
2
Vanguard Group
Pennsylvania
$27K
Citadel Advisors
3
Citadel Advisors
Florida
$16K -$16.6K -21 -49%
Morgan Stanley
4
Morgan Stanley
New York
$6K
RMAM
5
Raab & Moskowitz Asset Management
New Jersey
$2K +$2.38K +3 New
UBS Group
6
UBS Group
Switzerland
-$4K -5 Closed

MDVL Hedge Fund Activity: Q3 2018 in Review

6 of the 4,375 institutional investors tracked by Wall St. Rank reported a position in MedAvail Holdings, Inc. Common Stock (MDVL) for Q3 2018, worth a combined $140K — down 31% from $202K a quarter earlier.

Fund positioning in MDVL was balanced in Q3 2018: 1 fund opened new positions, 1 closed out, 0 added to existing stakes and 2 trimmed.

The largest buyer was Raab & Moskowitz Asset Management, opening a new position worth an estimated $2.38K. The largest seller was Citadel Advisors, cutting an estimated $16.6K.

  • 6 institutional investors held MedAvail Holdings, Inc. Common Stock (MDVL) as of Q3 2018, unchanged from Q2 2018.
  • Funds reported $140K of MedAvail Holdings, Inc. Common Stock stock for Q3 2018, down 31% quarter-over-quarter.
  • 1 fund opened new MedAvail Holdings, Inc. Common Stock positions in Q3 2018 and 1 closed out, a net change of 0 holders.
  • The largest MedAvail Holdings, Inc. Common Stock buyer in Q3 2018 was Raab & Moskowitz Asset Management, an estimated $2.38K added.
  • The largest MedAvail Holdings, Inc. Common Stock seller in Q3 2018 was Citadel Advisors, an estimated $16.6K sold.

Based on aggregated 13F filings for Q3 2018.